Our findings uncover high clinical value of the regulatory circuit of LIFR‐K620 acetylation, since most advanced PCa harbours PTEN mutations or overactivation of PI3K/AKT signalling. The gene discussed is LIFR; the disease is posterior cortical atrophy.